Truist Financial Corp grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.9% in the 4th ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

If an investor was to purchase shares of IDXX stock at the current price level of $433.50/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

This indicates that IDXX could be currently trading at a low price when comparing to its average historical PE Ratio range. The Estimated Value of the Stock is 530.25, versus the current stock ...

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia ...

We expect the trend to have continued in the fourth quarter of 2024, further boosting IDXX’s revenues. Revenues in global rapid assays are also likely to have benefited from higher net price ...